July 19, 2016
The Japanese Society of Medical Oncology issued a warning on July 13, urging cancer patients to avoid taking the immune checkpoint inhibitors Opdivo (nivolumab) and Yervoy (ipilimumab) privately imported from overseas by physicians or institutions not qualified for their use...read more